Anthranilamide inhibitors of factor Xa

被引:18
作者
Mendel, David [1 ]
Marquart, Angela L. [1 ]
Joseph, Sajan [1 ]
Waid, Philip [1 ]
Yee, Ying K. [1 ]
Tebbe, Anne Louise [1 ]
Ratz, Andrew M. [1 ]
Herron, David K. [1 ]
Goodson, Theodore [1 ]
Masters, John J. [1 ]
Franciskovich, Jeffry B. [1 ]
Tinsley, Jennifer M. [1 ]
Wiley, Michael R. [1 ]
Weir, Leonard C. [1 ]
Kyle, Jeffrey A. [1 ]
Klimkowski, Valentine J. [1 ]
Smith, Gerald F. [1 ]
Towner, Richard D. [1 ]
Froelich, Larry L. [1 ]
Buben, John [1 ]
Craft, Trelia J. [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
protease inhibitor; factor Xa; anticoagulant;
D O I
10.1016/j.bmcl.2007.06.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SAR about the B-ring of a series of N-2-aroyl anthranilamide factor Xa (tXa) inhibitors is described. B-ring o-aminoalkylether and B-ring p-amine probes of the S1' and S4 sites, respectively, afforded picomolar fXa inhibitors that performed well in in vitro anticoagulation assays. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4832 / 4836
页数:5
相关论文
共 23 条
[1]   Crystal structures of two potent nonamidine inhibitors bound to factor Xa [J].
Adler, M ;
Kochanny, MJ ;
Ye, B ;
Rumennik, G ;
Light, DR ;
Biancalana, S ;
Whitlow, M .
BIOCHEMISTRY, 2002, 41 (52) :15514-15523
[2]   Inhibition of Factor Xa: A potential target for the development of new anticoagulants [J].
Alexander J.H. ;
Singh K.P. .
American Journal of Cardiovascular Drugs, 2005, 5 (5) :279-290
[3]   Progress in the discovery of Factor Xa inhibitors [J].
Casimiro-Garcia, A ;
Dudley, DA ;
Heemstra, RJ ;
Filipski, KJ ;
Bigge, CF ;
Edmunds, JJ .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (02) :119-145
[4]   Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors [J].
Chou, YL ;
Davey, DD ;
Eagen, KA ;
Griedel, BD ;
Karanjawala, R ;
Phillips, GB ;
Sacchi, KL ;
Shaw, KJ ;
Wu, SC ;
Lentz, D ;
Liang, AM ;
Trinh, L ;
Morrissey, MM ;
Kochanny, MJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) :507-511
[5]   Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa [J].
Fevig, John M. ;
Cacciola, Joseph ;
Buriak, Joseph, Jr. ;
Rossi, Karen A. ;
Knabb, Robert M. ;
Luettgen, Joseph M. ;
Wong, Pancras C. ;
Bai, Stephen A. ;
Wexler, Ruth R. ;
Lam, Patrick Y. S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) :3755-3760
[6]   Heterogeneity of synthetic factor Xa inhibitors [J].
Gerotziafas, GT ;
Samama, MM .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (30) :3855-3876
[7]   A new oral anticoagulant:: The 50-year challenge [J].
Gustafsson, D ;
Bylund, R ;
Antonsson, T ;
Nilsson, I ;
Nyström, JE ;
Eriksson, U ;
Bredberg, U ;
Teger-Nilsson, AC .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :649-659
[8]  
Haas Sylvia, 2005, Curr Hematol Rep, V4, P335
[9]   1,2-dibenzamidobenzene inhibitors of human factor Xa [J].
Herron, DK ;
Goodson, T ;
Wiley, MR ;
Weir, LC ;
Kyle, JA ;
Yee, YK ;
Tebbe, AL ;
Tinsley, JM ;
Mendel, D ;
Masters, JJ ;
Franciskovich, JB ;
Sawyer, JS ;
Beight, DW ;
Ratz, AM ;
Milot, G ;
Hall, SE ;
Klimkowski, VJ ;
Wikel, JH ;
Eastwood, BJ ;
Towner, RD ;
Gifford-Moore, DS ;
Craft, TJ ;
Smith, GF .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (05) :859-872
[10]   Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa [J].
Kochanny, Monica J. ;
Adler, Marc ;
Ewing, Janice ;
Griedel, Brian D. ;
Ho, Elena ;
Karanjawala, Rushad ;
Lee, Wheeseong ;
Lentz, Dao ;
Liang, Amy M. ;
Morrissey, Michael M. ;
Phillips, Gary B. ;
Post, Joseph ;
Sacchi, Karna L. ;
Sakata, Steven T. ;
Subramanyam, Babu ;
Vergona, Ron ;
Walters, Janette ;
White, Kathy A. ;
Whitlow, Marc ;
Ye, Bin ;
Zhao, Zuchun ;
Shaw, Kenneth J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (05) :2127-2146